Inhibiting NF-κB-S100A11 signaling and targeting S100A11 for anticancer effects of demethylzeylasteral in human colon cancer.

MLA

Li, Wenqing, et al. “Inhibiting NF-ΚB-S100A11 Signaling and Targeting S100A11 for Anticancer Effects of Demethylzeylasteral in Human Colon Cancer.” Biomedicine & Pharmacotherapy, vol. 168, Dec. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115725.

APA

Li, W., Han, F., Tang, K., Ding, C., Xiong, F., Xiao, Y., Li, C., Liang, Q., Lee, K. Y., Lee, I.-S., & Gao, H. (2023). Inhibiting NF-κB-S100A11 signaling and targeting S100A11 for anticancer effects of demethylzeylasteral in human colon cancer. Biomedicine & Pharmacotherapy, 168, N.PAG. https://doi.org/10.1016/j.biopha.2023.115725

Chicago

Li, Wenqing, Fubo Han, Kaifan Tang, Chengjie Ding, Fen Xiong, Yina Xiao, Chen Li, et al. 2023. “Inhibiting NF-ΚB-S100A11 Signaling and Targeting S100A11 for Anticancer Effects of Demethylzeylasteral in Human Colon Cancer.” Biomedicine & Pharmacotherapy 168 (December): N.PAG. doi:10.1016/j.biopha.2023.115725.